AEterna Zentaris Reports Fourth Quarter And Full-Year 2015 Financial And Operating Results
CHARLESTON, S.C.--(BUSINESS WIRE)--Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health, today reported financial and operating results for the fourth quarter and year ended December 31, 2015.